In lung cancer cases, some reports have indicated that loss of IL-10 in lung tumors may promote tumor progression and result in poor clinical outcomes in patients; however, an opposite effect has been reported in other studies [23]–[29]. The gene discussed is IL10; the disease is lung carcinoma.